Dexcom Reports Third Quarter 2019 Financial Results

Go back to Dexcom Reports Third Quarter 2019 Financial Results

DexCom (DXCM) Tops Q3 EPS by 45c, Raises FY Guidance

November 6, 2019 4:29 PM EST

DexCom (NASDAQ: DXCM) reported Q3 EPS of $0.65, $0.45 better than the analyst estimate of $0.20. Revenue for the quarter came in at $396.3 million versus the consensus estimate of $347.96 million.

GUIDANCE:

DexCom sees FY2019 revenue of $1.43-1.45 billion, versus the consensus of $1.37... More